Differences beta-adrenergic neuroeffector mechanisms ischemic versus idiopathic cardiomyopathy BACKGROUND content activities components beta-adrenergic receptor-G protein-adenylate cyclase complex adrenergic neurotransmitter levels left right ventricular myocardial preparations end-stage human hearts patients idiopathic cardiomyopathy IDC ischemic cardiomyopathy ISCDC METHODS RESULTS results data nonfailing hearts organ donors ISCDC ventricles IDC right ventricles degree total beta- downregulation contrast IDC right ventricles isolated tissue preparations ISCDC right ventricles degree subsensitivity inotropic effect isoproterenol degree functional uncoupling right ventricular ISCDC beta-receptors mechanical response addition relative IDC ventricles preparations ISCDC ventricle subsensitivity beta-agonist-mediated adenylate cyclase stimulation functional uncoupling left ventricular ISCDC beta-receptors cyclic AMP generation uncoupling beta-receptors ISCDC right ventricles result abnormalities protein activation adenylate cyclase age- cardiac function-matched respective right IDC ventricles ISCDC ventricles stimulation adenylate cyclase NaF forskolin change stimulation ISCDC right ventricles stimulation nonhydrolyzable guanine Gpp NH IDC ventricles selective IDC ventricles ISCDC ventricles decrease stimulation adenylate cyclase Tissue neurotransmitter levels pertussis toxin-catalyzed ADP ribosylation similar extents IDC ISCDC CONCLUSIONS data important differences regulatory behavior components beta-adrenergic receptor-G protein-adenylate cyclase complex IDC versus ISCDC distinct pathophysiologies types heart muscle disease 